12.00
price up icon1.01%   0.12
after-market Dopo l'orario di chiusura: 12.00
loading
Precedente Chiudi:
$11.88
Aprire:
$11.98
Volume 24 ore:
1.66M
Relative Volume:
0.75
Capitalizzazione di mercato:
$851.32M
Reddito:
$114.04M
Utile/perdita netta:
$-330.15M
Rapporto P/E:
-2.537
EPS:
-4.73
Flusso di cassa netto:
$-274.85M
1 W Prestazione:
-2.91%
1M Prestazione:
+38.89%
6M Prestazione:
+115.05%
1 anno Prestazione:
-29.41%
Intervallo 1D:
Value
$11.25
$12.03
Intervallo di 1 settimana:
Value
$11.25
$12.46
Portata 52W:
Value
$2.21
$19.71

Phathom Pharmaceuticals Inc Stock (PHAT) Company Profile

Name
Nome
Phathom Pharmaceuticals Inc
Name
Telefono
(877) 742-8466
Name
Indirizzo
100 CAMPUS DRIVE,, FLORHAM PARK, NJ
Name
Dipendente
427
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PHAT's Discussions on Twitter

Confronta PHAT con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PHAT
Phathom Pharmaceuticals Inc
12.00 840.68M 114.04M -330.15M -274.85M -4.73
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
396.93 102.81B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
453.54 58.59B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
567.22 61.25B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ARGX
Argen X Se Adr
733.66 43.23B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
318.73 36.53B 3.81B -644.79M -669.77M -6.24

Phathom Pharmaceuticals Inc Stock (PHAT) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-02-14 Iniziato Cantor Fitzgerald Overweight
2024-05-03 Iniziato Stifel Buy
2024-01-05 Reiterato Needham Buy
2023-08-09 Iniziato H.C. Wainwright Buy
2023-05-11 Aggiornamento Evercore ISI In-line → Outperform
2023-03-13 Iniziato Craig Hallum Buy
2022-10-21 Iniziato Jefferies Buy
2022-05-06 Downgrade Evercore ISI Outperform → In-line
2021-05-12 Aggiornamento Goldman Sell → Neutral
2021-02-17 Iniziato BMO Capital Markets Outperform
2021-02-02 Iniziato Guggenheim Buy
2020-06-26 Downgrade Goldman Neutral → Sell
2019-11-20 Iniziato Evercore ISI Outperform
2019-11-19 Iniziato Goldman Neutral
2019-11-19 Iniziato Jefferies Buy
2019-11-19 Iniziato Needham Buy
Mostra tutto

Phathom Pharmaceuticals Inc Borsa (PHAT) Ultime notizie

pulisher
Sep 03, 2025

Is Phathom Pharmaceuticals Inc. a turnaround storyEarnings Growth Report & Technical Confirmation Alerts - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Detecting support and resistance levels for Phathom Pharmaceuticals Inc.Weekly Market Summary & Daily Growth Stock Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Phathom Pharmaceuticals Inc. backed by strong institutional buyingJuly 2025 Drop Watch & Risk Managed Investment Signals - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Chart based analysis of Phathom Pharmaceuticals Inc. trendsStock Surge & Safe Swing Trade Setup Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Momentum divergence signals in Phathom Pharmaceuticals Inc. chartWeekly Profit Recap & Precise Swing Trade Entry Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Visual analytics tools that track Phathom Pharmaceuticals Inc. performanceJuly 2025 Drop Watch & Fast Moving Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to forecast Phathom Pharmaceuticals Inc. trends using time seriesTake Profit & Fast Momentum Entry Tips - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Institutional scanner results for Phathom Pharmaceuticals Inc.Market Activity Report & Reliable Volume Spike Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Phathom Pharmaceuticals Inc. a top pick in the sector2025 Risk Factors & Verified Short-Term Trading Plans - khodrobank.com

Sep 03, 2025
pulisher
Sep 03, 2025

Advanced analytics toolkit walkthrough for Phathom Pharmaceuticals Inc.Earnings Summary Report & Daily Momentum Trading Reports - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

Is Phathom Pharmaceuticals Inc. still worth holding after the dipWeekly Trade Report & Community Verified Trade Alerts - Newser

Sep 03, 2025
pulisher
Sep 03, 2025

How to read the order book for Phathom Pharmaceuticals Inc.Portfolio Risk Summary & Fast Moving Trade Plans - Newser

Sep 03, 2025
pulisher
Sep 02, 2025

Combining machine learning predictions for Phathom Pharmaceuticals Inc.Wall Street Watch & Real-Time Chart Breakout Alerts - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Why Phathom Pharmaceuticals Inc. is moving todayPortfolio Update Report & Risk Adjusted Swing Trade Ideas - Newser

Sep 02, 2025
pulisher
Sep 02, 2025

Institution Moves: Will Phathom Pharmaceuticals Inc. benefit from rate cuts2025 Valuation Update & Safe Capital Growth Plans - khodrobank.com

Sep 02, 2025
pulisher
Sep 01, 2025

Using data filters to optimize entry into Phathom Pharmaceuticals Inc.Volume Spike & Pattern Based Trade Signal System - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

Signal strength of Phathom Pharmaceuticals Inc. stock in tech scannersMarket Activity Report & Real-Time Stock Price Movement Reports - Newser

Sep 01, 2025
pulisher
Sep 01, 2025

How moving averages guide Phathom Pharmaceuticals Inc. tradingEarnings Trend Report & Verified Technical Trade Signals - Newser

Sep 01, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 22:05:23 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Backtesting results for Phathom Pharmaceuticals Inc. trading strategiesPortfolio Value Report & Accurate Trade Setup Notifications - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Will a bounce in Phathom Pharmaceuticals Inc. offer an exitJuly 2025 Fed Impact & Verified Swing Trading Watchlist - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can a trend reversal in Phathom Pharmaceuticals Inc. lead to recoveryEarnings Growth Summary & Stepwise Swing Trade Plans - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Phathom Pharmaceuticals Inc. stock retracement – recovery analysis2025 Retail Activity & Real-Time Price Movement Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Is Phathom Pharmaceuticals Inc. the Top Chart Pick This Week getLinesFromResByArray error: size == 0 - thegnnews.com

Aug 31, 2025
pulisher
Aug 31, 2025

What’s next for Phathom Pharmaceuticals Inc. stock priceTrade Analysis Summary & Weekly High Return Stock Opportunities - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What the charts say about Phathom Pharmaceuticals Inc. today2025 Sector Review & Daily Chart Pattern Signal Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 04:29:11 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

What makes Phathom Pharmaceuticals Inc. stock price move sharplyWeekly Trend Summary & Risk Managed Investment Strategies - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Published on: 2025-08-31 02:28:01 - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

How hedge fund analytics apply to Phathom Pharmaceuticals Inc. stockJuly 2025 Drop Watch & Growth Focused Stock Reports - Newser

Aug 31, 2025
pulisher
Aug 31, 2025

Can you recover from losses in Phathom Pharmaceuticals Inc.Trade Risk Summary & Technical Pattern Based Signals - Newser

Aug 31, 2025
pulisher
Aug 30, 2025

Historical volatility pattern of Phathom Pharmaceuticals Inc. visualizedPortfolio Return Summary & Precise Entry and Exit Recommendations - Newser

Aug 30, 2025
pulisher
Aug 30, 2025

Analysts Apply Wyckoff Model to Phathom Pharmaceuticals Inc. Stock getLinesFromResByArray error: size == 0 - 더경남뉴스

Aug 30, 2025

Phathom Pharmaceuticals Inc Azioni (PHAT) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading

Phathom Pharmaceuticals Inc Azioni (PHAT) insider trading

Commercio interno Relazione Data Transazione Costo #Azioni Valore ($) #Azioni Totale
Topper James N
Director
May 21 '25
Buy
3.86
3,780
14,609
59,403
Topper James N
Director
May 14 '25
Buy
3.32
6,300
20,919
55,623
Topper James N
Director
May 13 '25
Buy
3.16
1,120
3,543
49,323
Topper James N
Director
May 09 '25
Buy
3.22
35,602
114,616
35,602
Topper James N
Director
May 12 '25
Buy
3.04
12,601
38,301
48,203
Parikh Asit
Director
May 06 '25
Buy
2.60
5,000
13,000
90,500
Parikh Asit
Director
May 07 '25
Buy
2.40
5,000
11,984
95,500
Henderson Molly
CFO and CBO
Apr 07 '25
Sale
4.55
3,678
16,740
89,868
Parikh Asit
Director
Sep 10 '24
Option Exercise
11.72
7,500
87,900
93,000
Parikh Asit
Director
Mar 13 '25
Buy
4.42
10,000
44,200
85,500
$85.44
price down icon 1.75%
$27.38
price up icon 1.11%
$23.80
price up icon 1.19%
$103.50
price up icon 3.07%
$142.53
price down icon 0.68%
biotechnology ONC
$318.73
price down icon 5.21%
Capitalizzazione:     |  Volume (24 ore):